Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers - PubMed (original) (raw)
Randomized Controlled Trial
. 2008 Feb 15;32(2):568-75.
doi: 10.1016/j.pnpbp.2007.10.020. Epub 2007 Nov 1.
Affiliations
- PMID: 18060675
- PMCID: PMC2275606
- DOI: 10.1016/j.pnpbp.2007.10.020
Randomized Controlled Trial
Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers
Laure Buydens-Branchey et al. Prog Neuropsychopharmacol Biol Psychiatry. 2008.
Abstract
Objective: Mounting evidence indicates that low levels of n-3 polyunsaturated fatty acids (PUFAs) play a role in the pathophysiology of a large number of psychiatric disorders. In light of the suboptimal n-3 PUFAs intake due to poor dietary habits among substance abusers and the strong associations between aggression, anxiety and substance use disorders we examined if insurance of adequate intakes of n-3 PUFAs with supplementation would decrease their anger and anxiety scores.
Method: Substance abusers (n=22) were assigned to either 3 g of n-3 PUFAs, mainly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) or soybean oil in identically looking capsules. The trial was double-blind, randomized and lasted 3 months. Anger and anxiety scales were administered at baseline and once a month thereafter. Blood samples were collected at baseline and at the end of the trial.
Results: Patients' dietary intakes of n-3 PUFAs fell below recommended levels. Assignment to n-3 PUFA treatment was accompanied by significant decreases in anger and anxiety scores compared to placebo assignment. These changes were associated with increases in plasma levels of both EPA and DHA but an increase in EPA was more robustly correlated with low end-of-trial anxiety scores and an increase in DHA was more robustly correlated with low end-of-trial anger scores.
Conclusion: These pilot data indicate that ensuring adequate n-3 PUFA intake via supplementation benefits substance abusers by reducing their anger and anxiety levels. The strong correlations between an increase in plasma EPA and lower anxiety scores and between an increase in plasma DHA and lower anger scores suggests a need for the further exploration of the differential responses to these two n-3 PUFAs in different psychiatric conditions.
Figures
Figure 1
Anger scores of substance abusers during a 3-month administration of n-3 PUFAs or placebo. Values are means±SEM. A comparison of the scores of the two patient groups by a repeated measures ANCOVA, with baseline values as covariates, revealed a significant difference (p=.040). The effect size was large (f=.506).
Figure 2
Anxiety scores of substance abusers during a 3-month administration of n-3 PUFAs or placebo. Values are means±SEM. A comparison of the scores of the two patient groups by a repeated measures ANCOVA, with baseline values as covariates, revealed a significant difference (p=.023). The effect size was large (f=.567).
Similar articles
- n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers.
Buydens-Branchey L, Branchey M. Buydens-Branchey L, et al. J Clin Psychopharmacol. 2006 Dec;26(6):661-5. doi: 10.1097/01.jcp.0000246214.49271.f1. J Clin Psychopharmacol. 2006. PMID: 17110827 Clinical Trial. - Long-chain n-3 polyunsaturated fatty acids decrease feelings of anger in substance abusers.
Buydens-Branchey L, Branchey M. Buydens-Branchey L, et al. Psychiatry Res. 2008 Jan 15;157(1-3):95-104. doi: 10.1016/j.psychres.2007.01.004. Epub 2007 Sep 27. Psychiatry Res. 2008. PMID: 17900705 Free PMC article. Clinical Trial. - Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K, Kralovec J, Bailey-Hall E, Smeberg V, Stark JG, Salem N Jr. Yurko-Mauro K, et al. Lipids Health Dis. 2015 Sep 2;14:99. doi: 10.1186/s12944-015-0109-z. Lipids Health Dis. 2015. PMID: 26328782 Free PMC article. Clinical Trial. - A meta-analytic review of polyunsaturated fatty acid compositions in dementia.
Lin PY, Chiu CC, Huang SY, Su KP. Lin PY, et al. J Clin Psychiatry. 2012 Sep;73(9):1245-54. doi: 10.4088/JCP.11r07546. Epub 2012 Aug 7. J Clin Psychiatry. 2012. PMID: 22938939 Review.
Cited by
- Curcumin boosts DHA in the brain: Implications for the prevention of anxiety disorders.
Wu A, Noble EE, Tyagi E, Ying Z, Zhuang Y, Gomez-Pinilla F. Wu A, et al. Biochim Biophys Acta. 2015 May;1852(5):951-61. doi: 10.1016/j.bbadis.2014.12.005. Epub 2014 Dec 27. Biochim Biophys Acta. 2015. PMID: 25550171 Free PMC article. - Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.
Lotrich FE, Sears B, McNamara RK. Lotrich FE, et al. J Psychosom Res. 2013 Nov;75(5):475-83. doi: 10.1016/j.jpsychores.2013.07.012. Epub 2013 Jul 26. J Psychosom Res. 2013. PMID: 24182638 Free PMC article. - Association of Use of Omega-3 Polyunsaturated Fatty Acids With Changes in Severity of Anxiety Symptoms: A Systematic Review and Meta-analysis.
Su KP, Tseng PT, Lin PY, Okubo R, Chen TY, Chen YW, Matsuoka YJ. Su KP, et al. JAMA Netw Open. 2018 Sep 7;1(5):e182327. doi: 10.1001/jamanetworkopen.2018.2327. JAMA Netw Open. 2018. PMID: 30646157 Free PMC article. - The Effect of Very-Long-Chain _n_-3 Polyunsaturated Fatty Acids in the Central Nervous System and Their Potential Benefits for Treating Alcohol Use Disorder: Reviewing Pre-Clinical and Clinical Data.
Carvajal F, Sánchez-Gil A, Cardona D, Rincón-Cervera MA, Lerma-Cabrera JM. Carvajal F, et al. Nutrients. 2023 Jun 30;15(13):2993. doi: 10.3390/nu15132993. Nutrients. 2023. PMID: 37447319 Free PMC article. Review. - OMEGA-3 Interventions in Alcohol Dependence and Related Outcomes: A Systematic Review and Propositions.
Galduróz JCF, Bezerra AG, Pires GN, Pauluci R, Noto AR. Galduróz JCF, et al. Curr Neuropharmacol. 2020;18(5):456-462. doi: 10.2174/1570159X18666200128120729. Curr Neuropharmacol. 2020. PMID: 31989899 Free PMC article.
References
- Alessandri JM, Guesnet P, Vancassel S, Astorg P, Denis I, Langelier B, et al. Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life. Reprod Nutr Dev. 2004;44:509–38. - PubMed
- Buydens-Branchey L, Branchey M. N-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol. 2006;26:661–5. - PubMed
- Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Lawrence Earlbaum; Hillsdale, NJ: 1988.
- First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM IV Axis I Disorders (SCID-I) American Psychiatric Press; Washington, DC: 1997.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials